Neurodegenerative drug discovery trapped in biomedical reductionism: How nanotech obscures systemic care gaps for aging societies
Original framing: “Nanoscale tech tracks proteins inside living neurons to guide Alzheimer's and Parkinson's drug discovery” — Phys.org
Marginalized communities—particularly Black, Indigenous, and rural populations—experience neurodegeneration differently due to systemic inequities, yet their voices are absent from drug-discovery narratives. For example, African American patients with Parkinson’s are more likely to be misdiagnosed with psychiatric disorders due to racial biases in medical training, while Indigenous Australians face barriers to accessing early diagnosis in remote regions. Caregivers, who are overwhelmingly women of color, report feeling excluded from clinical trials and decision-making processes, despite bearing the emotional and financial burden of neurodegenerative diseases. The NASTIC platform’s focus on 'early drug discovery' risks perpetuating these inequities by centering academic labs and biotech startups while ignoring community-based research, such as the work of the *Black Women’s Health Imperative* or Indigenous-led health initiatives like Australia’s *Close the Gap* campaign.
The NASTIC platform’s nanoscale innovation exemplifies a broader pattern in neurodegenerative research: the pursuit of molecular precision at the expense of systemic, equitable, and culturally grounded solutions.
While the technology offers unprecedented insights into protein dynamics, its framing obscures critical dimensions—from the historical cycles of hype and failure in drug discovery to the Indigenous and cross-cultural knowledge systems that already address root causes of cognitive decline. The power structures at play are evident in how academic and corporate narratives center 'early drug discovery' while marginalizing voices of caregivers, Indigenous healers, and public health advocates, who collectively hold the keys to sustainable solutions. The trickster dimension reveals the irony of treating neurodegeneration as a solvable puzzle while ignoring the larger systems of environmental injustice, colonial trauma, and healthcare inequity that fuel its rise. To move forward, the field must embrace a *relational* model of neuron health—one that integrates nanoscale science with Indigenous stewardship, public health policies, and cross-cultural care practices, ensuring that technological breakthroughs serve the many, not just the few.